The arc of the vector database story has followed a classic path: A pervasive hype cycle, followed by introspection, ...
Krystal Biotech drives Vyjuvek growth, premium margins, global expansion, a $1B goal, and pipeline data ahead with a $219.50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback